These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32617304)

  • 1. Hashimoto's thyroiditis might increase polycystic ovary syndrome and associated comorbidities risks in Asia.
    Ho CW; Chen HH; Hsieh MC; Chen CC; Hsu SP; Yip HT; Kao CH
    Ann Transl Med; 2020 Jun; 8(11):684. PubMed ID: 32617304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between Hashimoto's thyroiditis and polycystic ovary syndrome: A systematic review and meta-analysis.
    Hu X; Chen Y; Shen Y; Zhou S; Fei W; Yang Y; Que H
    Front Endocrinol (Lausanne); 2022; 13():1025267. PubMed ID: 36387911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hashimoto's thyroiditis worsens ovaries in polycystic ovary syndrome patients compared to Anti-Müllerian hormone levels.
    Serin AN; Birge Ö; Uysal A; Görar S; Tekeli F
    BMC Endocr Disord; 2021 Mar; 21(1):44. PubMed ID: 33750377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparative Study on Insulin Secretion, Insulin Resistance and Thyroid Function in Patients with Polycystic Ovary Syndrome with and without Hashimoto's Thyroiditis.
    Zhao H; Zhang Y; Ye J; Wei H; Huang Z; Ning X; Fu X
    Diabetes Metab Syndr Obes; 2021; 14():1817-1821. PubMed ID: 33953581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the effect of hashimoto's thyroiditis and insulin resistance on ovarian volume in patients with polycystic ovary syndrome.
    Gencer G; Serin AN; Gencer K
    BMC Womens Health; 2023 Feb; 23(1):86. PubMed ID: 36829146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exome sequencing to explore the possibility of predicting genetic susceptibility to the joint occurrence of polycystic ovary syndrome and Hashimoto's thyroiditis.
    Zeber-Lubecka N; Suchta K; Kulecka M; Kluska A; Piątkowska M; Dabrowski MJ; Jankowska K; Grymowicz M; Smolarczyk R; Hennig EE
    Front Immunol; 2023; 14():1193293. PubMed ID: 37545519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of glucose and lipid metabolism in patients with polycystic ovary syndrome with and without Hashimoto's thyroiditis.
    Jia C; Zhang L; Liu W; Zhang X; Wu H
    Medicine (Baltimore); 2023 Mar; 102(11):e33205. PubMed ID: 36930082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of Hashimoto's thyroiditis in patients with polycystic ovary syndrome: does the imbalance between estradiol and progesterone play a role?
    Arduc A; Aycicek Dogan B; Bilmez S; Imga Nasiroglu N; Tuna MM; Isik S; Berker D; Guler S
    Endocr Res; 2015; 40(4):204-10. PubMed ID: 25822940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Mitochondrial Variants with the Joint Occurrence of Polycystic Ovary Syndrome and Hashimoto's Thyroiditis.
    Zeber-Lubecka N; Kulecka M; Suchta K; Dąbrowska M; Ciebiera M; Hennig EE
    Antioxidants (Basel); 2023 Nov; 12(11):. PubMed ID: 38001836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Risk of Polycystic Ovary Syndrome and It's Comorbidities in Women with Autoimmune Thyroid Disease.
    Ho CW; Chen HH; Hsieh MC; Chen CC; Hsu SP; Yip HT; Kao CH
    Int J Environ Res Public Health; 2020 Apr; 17(7):. PubMed ID: 32252386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lifestyle intervention towards Mediterranean Diet, physical activity adherence and anthropometric parameters in normal weight women with Polycystic Ovary Syndrome or Hashimoto's Thyroiditis - preliminary study.
    Kamińska W; Wiśniewska K; Okręglicka K; Pazura I; Nitsch-Osuch A
    Ann Agric Environ Med; 2023 Mar; 30(1):111-117. PubMed ID: 36999863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graves' disease could increase polycystic ovary syndrome and comorbidities in Taiwan.
    Chen HH; Chen CC; Hsieh MC; Ho CW; Hsu SP; Yip HT; Kao CH
    Curr Med Res Opin; 2020 Jun; 36(6):1063-1067. PubMed ID: 32297812
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypertension Risk in Young Women With Polycystic Ovary Syndrome: A Nationwide Population-Based Cohort Study.
    Wu CH; Chiu LT; Chang YJ; Lee CI; Lee MS; Lee TH; Wei JC
    Front Med (Lausanne); 2020; 7():574651. PubMed ID: 33072787
    [No Abstract]   [Full Text] [Related]  

  • 14. Hashimoto's thyroiditis, risk of coronary heart disease, and L-thyroxine treatment: a nationwide cohort study.
    Chen WH; Chen YK; Lin CL; Yeh JH; Kao CH
    J Clin Endocrinol Metab; 2015 Jan; 100(1):109-14. PubMed ID: 25272307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer risk in patients with Hashimoto's thyroiditis: a nationwide cohort study.
    Chen YK; Lin CL; Cheng FT; Sung FC; Kao CH
    Br J Cancer; 2013 Oct; 109(9):2496-501. PubMed ID: 24084773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Susceptibility to Joint Occurrence of Polycystic Ovary Syndrome and Hashimoto's Thyroiditis: How Far Is Our Understanding?
    Zeber-Lubecka N; Hennig EE
    Front Immunol; 2021; 12():606620. PubMed ID: 33746952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms in endocrinology: thyroid and polycystic ovary syndrome.
    Gaberšček S; Zaletel K; Schwetz V; Pieber T; Obermayer-Pietsch B; Lerchbaum E
    Eur J Endocrinol; 2015 Jan; 172(1):R9-21. PubMed ID: 25422352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interplay of oxidative stress and immune dysfunction in Hashimoto's thyroiditis and polycystic ovary syndrome: a comprehensive review.
    Batóg G; Dołoto A; Bąk E; Piątkowska-Chmiel I; Krawiec P; Pac-Kożuchowska E; Herbet M
    Front Immunol; 2023; 14():1211231. PubMed ID: 37588599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of ovarian reserve in Hashimoto's thyroiditis.
    Tuten A; Hatipoglu E; Oncul M; Imamoglu M; Acikgoz AS; Yilmaz N; Ozcil MD; Kaya B; Misirlioglu AM; Sahmay S
    Gynecol Endocrinol; 2014 Oct; 30(10):708-11. PubMed ID: 24905723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiometabolic risks in polycystic ovary syndrome: long-term population-based follow-up study.
    Behboudi-Gandevani S; Ramezani Tehrani F; Hosseinpanah F; Khalili D; Cheraghi L; Kazemijaliseh H; Azizi F
    Fertil Steril; 2018 Dec; 110(7):1377-1386. PubMed ID: 30503137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.